Alpha-synuclein (Syn) is a cytosolic, soluble, and unstructured protein, which may also associate with membranes by acquiring an alpha-helical conformation. High Syn concentrations are present in genetic Parkinson's disease (PD) due to duplication/triplication of SNCA gene, and are also associated with polymorphisms found in idiopathic PD cases 1 . Syn has been shown to act on several intracellular targets, and to alter synaptic function. The discovery of the presence of Syn in cerebrospinal fluid and of its release from neurons, as demonstrated by numerous studies 2 , suggests that Syn-driven pathology may spread in the brain, although the mechanism of Syn release is still unclear. There is evidence that Syn overexpression modifies the structure of the cellular membrane, however a possible effect of excess Syn on the pre-or post-synaptic terminal from the extracellular milieu has yet to be fully analyzed.
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Our study shows that, although Syn treatment leaves the total cellular cholesterol content unchanged, it decreases the level of the lipid in the plasma membrane. Interestingly, this effect is accompanied by a translocation of Ca v 2.2 from high to low cholesterol compartments. Lipid rafts are patches in the membrane with high cholesterol content that constitute ordered lipid domains, compared to the disordered bilayer. We propose that the demonstrated shift of Ca v 2.2 channels into non-raft domains, where lower energy is required for membrane deformation, favours channel transition to the open state. The net activity of the channel will then derive from a balance between its localization in the membrane and the relative localization of its regulatory proteins.
Reports in the literature show that cholesterol depletion by methyl-β-cyclodextrin induces an increase in calcium current, as we observe with Syn treatment. Moreover cholesterol loading of neurons causes a clear decrease in calcium current 4 . We show that methyl-β-cyclodextrin causes an increase in calcium entry, but it also decreases synaptic vesicles release by altering membrane curvature 5 ; we further show that extracellular Syn, acting only at the plasma membrane level, is able to couple the increase in Ca v 2.2 activity and intracellular calcium levels with an increase in neurotransmitter release. Conversely, cholesterol loading causes a concentration-dependent decrease in excitatory postsynaptic potential amplitude in SCGN synapses, consistent with a reduction in calcium current (Figure 1) .
The effect of Syn on cholesterol is still unknown, whether inducing an internalization of cholesterol-rich domains, or a change in size/number of lipid rafts; however, the effect of Syn 
